Fibulin-6 expression and anoikis in human salivary gland epithelial cells: Implications in Sjogren's syndrome

International Immunology

Volumn 21, Issue 3, 2009, Pages 303-311

  Sisto, Margherita ^a   D'Amore, Massimo ^a   Lofrumento, Dario Domenico ^b   Scagliusi, Pasquale ^a   D'Amore, Simona ^a   Mitolo, Vincenzo ^a   Lisi, Sabrina ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

Anti Ro SSA; Autoimmune; Dysregulation; Extracellular matrix; Hemicentin

Indexed keywords

FIBULIN 6; MESSENGER RNA; RO ANTIBODY; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANOIKIS; ARTICLE; CELL DEATH; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND DISEASE; SALIVARY GLAND FUNCTION; SJOEGREN SYNDROME;

AGED; ANOIKIS; AUTOANTIBODIES; AUTOANTIGENS; CELLS, CULTURED; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 61349176989     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp001     Document Type: Article

References (49)

1. Rosso, F., Giordano, A., Barbarisi, M. and Barbarisi, A. 2004. From cell-ECM interactions to tissue engineering. J. Cell. Physiol. 199:174.
2. Egeblad, M. and Werb, Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161.
3. Jackson, C. J., Arkell, J. and Nguyen, M. 1998. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1). Ann. Rheum. Dis. 57:158.
4. Hagios, C., Lochter, A. and Bissell, M. J. 1998. Tissue architecture: the ultimate regulator of epithelial function? Philos. Trans. R. Soc. Lond. B Biol. Sci. 353:857.
5. Bissell, M. J. 1998. Glandular structure and gene expression. Lessons from the mammary gland. Ann. N. Y. Acad. Sci. 842:1.
6. Talal, N. 1992. Sjögren's syndrome: Historical overview and clinical spectrum of disease. Rheum. Dis. Clin. North Am. 18:507.
7. Frisch, S. M. and Screaton, R. A. 2001. Anoikis mechanisms. Curr. Opin. Cell Biol. 13:555.
8. Argraves, W. S., Greene, L. M., Cooley, M. A. and Gallagher, W. M. 2003. Fibulins: Physiological and disease perspectives. EMBO Rep. 4:1127.
9. Gallagher, W. M., Argentini, M., Sierra, V., Bracco, L., Debussche, L. and Conseiller, E. 1999. MBP1: A novel mutant p53-specific protein partner with oncogenic properties. Oncogene 18:3608.
10. Godyna, S., Diaz-Ricart, M. and Argraves, W. S. 1996. MBP1: A novel mutant p53-specific protein partner with oncogenic properties. Blood 88:2569.
11. Qing, J., Maher, V. M., Tran, H., Argraves,W. S., Dunstan, R.W. and McCormick, J. J. 1997. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 15:2159.
12. Hayashido, Y., Lucas, A., Rougeot, C., Godyna, S., Argraves, W.S. and Rochefort, H. 1998. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int. J. Cancer 75:654.
13. Nakamura, T., Ruiz-Lozano, P., Lindner, V. et al. 1999. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J. Biol. Chem. 274:22483.
14. Kowal, R. C., Jolsin, J. M., Olson, E. N. and Schultz, R. A. 1999. Assignment of fibulin-5 (FBLN5) to human chromosome 14q31 by in situ hybridization and radiation hybrid mapping. Cytogenet. Cell Genet. 87:2.
15. Xiang, Y., Sekine, T., Nakamura, H. et al. 2006. Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol. 176:3196.
16. Fox, P. C. 2007. Autoimmune diseases and Sjogren's syndrome: An autoimmune exocrinopathy. Ann. N. Y. Acad. Sci. 1098:15.
17. Párez, P., Goicovich, E., Alliende, C. et al. 2000. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 43:2807.
18. Santavirta, N., Konttinen, Y. T., Törnwall, J. et al. 1997. Neuro-peptides of the autonomic nervous system in Sjögren's syndrome. Ann. Rheum. Dis. 56:737.
19. Molina, C., Alliende, C., Aguilera, S. et al. 2006. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: Association with mononuclear cell infiltration. Ann. Rheum. Dis. 65:178.
20. Goicovich, E., Molina, C., Pérez, P. et al. 2003. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: Correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 48:2573.
21. Gilmore, A. P. 2005. Anoikis. Cell Death Differ. 12:1473.
22. Frisch, S. M. and Francis, H. 1994. Disruption of epithelial cellmatrix interactions induces apoptosis. J. Cell Biol. 124:619.
23. Williamson, M. R., Shuttleworth, A., Canfield, A., Black, R. A. and Kielty, C. M. 2007. The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment. Biomaterials 28:5307.
24. Zheng, Q., Davis, E. C., Richardson, J. A. et al. 2007. Molecular analysis of fibulin-5 function during de novo synthesis of elastic fibers. Mol. Cell Biol. 27:1083.
25. Schultz, D. W., Klein, M. L., Humpert, A. J. et al. 2003. Analysis of the ARMD1 locus: Evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum. Mol. Genet. 12:3315.
26. Xu, X., Dong, C. and Vogel, B. E. 2007. Hemicentins assemble on diverse epithelia in the mouse. J. Histochem. Cytochem. 55:119.
27. Hayashi, M., Merriam, J. E., Klaver, C. C. et al. 2004. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet. 25:111.
28. Sisto, M., Lisi, S., Castellana, D. et al. 2006. Autoantibodies from Sjögren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J. Autoimmun. 27:38.
29. Lisi, S., Sisto, M., Soleti, R. et al. 2007. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253. J. Oral. Pathol. Med. 36:511.
30. Lisi, S., D'Amore, M., Lofrumento, D. et al. 2008. Modulation of the Fcgamma receptors induced by anti-Ro and anti-La autoanti-bodies: observations in salivary gland cells. Rheumatol. Int. 22:943
31. Sens, D. A., Hintz, D.S., Rudisill, M. T., Sens, M. A. and Spicer, S.S. 1985. Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab. Invest. 52:559.
32. Kapsogeorgou, E. K., Dimitriou, I. D., Abu-Helu, R. F., Moutsupoulos, H. M. and Manoussakis, M. N. 2001. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: High expression of intercellular adhesion molecule-1 (ICAMA.1) in biopsy specimens and cultured cells., Clin. Exp. Immunol. 124:126.
33. Kapsogeorgou, E. K., Moutsopoulos, H. M. and Manoussakis, M.N. 2001. Functional expression of a costimulatory B7.2. (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J. Immunol. 166:3107.
34. Vitali, G., Bombardieri, S., Jonsson, R. et al. 2002. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European consensus group. Ann. Rheum. Dis. 61:554.
35. Huang, S. and Ingber, D. E. 1999. The structural and mechanical complexity of cell-growth control. Nat. Cell Biol. 1:E131.
36. Singh, A. B., Sugimoto, K. and Harris, R. C. 2007. Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype. J. Biol. Chem. 282:32890.
37. Grossmann, J. 2002. Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 7:247.
38. Wagenseil, J. E. and Mecham, R. P. 2007. New insights into elastic fiber assembly. Birth Defects Res, C Embryo Today 81:229.
39. Kostka, G., Giltay, R., Bloch, W. et al. 2001. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1 -deficient mice. Mol. Cell Biol. 21:7025.
40. Debeer, P., Schoenmakers, E. F., Twal, W. O. et al. 2002. The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J. Med Genet. 39:98.
41. Visconti, R. P., Barth, J. L., Keeley, F W. and Little, C. D. 2003. Codistribution analysis of elastin and related fibrillar proteins in early vertebrate development. Matrix Biol. 22: 109.
42. Weigell-Weber, M., Sarrá, G. M., Kotzot, D., Sandkuiji, L., Messmer, E. and Hergersberg, M. 2003. Genomewide homozy-gosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin-l) in a previously undescribed vitreoretinal dystrophy. Arch. Ophthalmol 121:1184.
43. Mullins, R. F., Olvera, M. A., Clark, A. F. and Stone, E. M. 2007. Fibulin-5 distribution in human eyes: Relevance to age-related macular degeneration. Exp. Eye Res. 84:378.
44. Loeys, B., Van Maldergem, L., Mortier, G. et al. 2002. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum. Mol. Genet. 11:2113.
45. Forti, S., Scanlan, M. J., Invernizzi, A. et al. 2002. Identification of breast cancer-restricted antigens by antibody screening- of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res. Treat. 73:245.
46. Greene, L. M., Twal, W. O., Duffy, M. J. et al. 2003. Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br. J. Cancer 88:871.
47. Fingleton, B. 2007. Matrix metalloproteinases as valid clinical targets. Curr. Pharm. Des. 13:333.
48. Cho, Y. G., Cho, M. L., Min, S. Y. and Kim, H. Y. 2007. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun. Rev. 7:65.
49. Pérez, R, Kwon, Y. J., Alliende, C. et al. 2005. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/ tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/ tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum. 52:2751.